MIT study reveals how specific cells in AD become vulnerable and resilient
The neurodegenerative condition is recognised as the most common form of dementia
Read Moreby Jen Brogan | Jul 29, 2024 | News | 0
The neurodegenerative condition is recognised as the most common form of dementia
Read Moreby Jen Brogan | Jun 17, 2024 | News | 0
Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020
Read Moreby Jen Brogan | May 17, 2024 | News | 0
Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
Read Moreby Jen Brogan | May 13, 2024 | News | 0
Bioluminescence used MRI to observe the dilation of luciferase in engineered blood vessels
Read Moreby Jen Brogan | Apr 30, 2024 | News | 0
An estimated 50% of human genes follow a circadian cycle, many of which are active in the liver
Read Moreby Jen Brogan | Apr 18, 2024 | News | 0
The Tyche model could help clinicians and researchers capture crucial information in images
Read Moreby Jen Brogan | Mar 21, 2024 | News | 0
The bacterial infection transmitted by ticks affects nearly half a million people in the US every year
Read Moreby Jen Brogan | Mar 8, 2024 | News | 0
The gamma treatment also shows potential for treating patients living with neurological diseases
Read Moreby Jen Brogan | Feb 21, 2024 | News | 0
Results showed robust responses in patients with pancreatic and colorectal cancer
Read Moreby Jen Brogan | Feb 12, 2024 | News | 0
The chip removes cells, which could become tumours, before they are implanted in a patient
Read Moreby Jen Brogan | Jan 23, 2024 | News | 0
The advancement could allow earlier detection of cancer in the blood and better treatment
Read Moreby Jen Brogan | Jan 11, 2024 | News | 0
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
